Industry News
Pharmaceutical Industry News
Following a string of defeats for…
Following a string of defeats for the industry in challenging the Inflation Reduction Act, Hail Mary efforts from a handful of companies to have their criticisms heard by the United States’ High Court have fallen
After an impressive phase 3…
After an impressive phase 3 showing last fall, AstraZeneca’s wager on CinCor Pharma and its aldosterone synthase inhibitor (ASI) baxdrostat has continued to pay off, with an FDA approval Monday that also advances the British
Merck and Kelun-Biotech have…
Merck and Kelun-Biotech have already notched four approvals in China for their TROP2-directed ADC sacituzumab tirumotecan. Now, after meeting the primary endpoints in a phase 3 trial of certain patients with endometrial cancer, the companies
Already tracking $5 billion in…
Already tracking $5 billion in annual sales, Enhertu has secured two new FDA approvals for treating early breast cancer. But while arriving nearly two months early, the adjuvant label comes with a catch.
As Bristol Myers looks for…
As Bristol Myers looks for suitable sites for a large U.S. manufacturing plant, Houston has emerged as one contender.
BeOne Medicines has tapped former…
BeOne Medicines has tapped former professional soccer goalkeeper Tim Howard as the face of its first major corporate campaign, which plays on how the company is geared up to “save” lives.
Top Drug Regulator Is Fired From the F.D.A.
Dr. Tracy Beth Hoeg said she did not know who had fired her or why, but the dismissal came amid tumult at the agency in recent days.
The FDA approved the Tecentriq…
The FDA approved the Tecentriq label expansion alongside Natera's Signatera as a companion diagnostic.
With the ink barely dry on…
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.
The company doubled sales of its…
The company doubled sales of its Biogen-partnered Alzheimer's disease treatment during its 2025 fiscal year.
The U.S. Supreme Court has issued…
The U.S. Supreme Court has issued an emergency order, temporarily blocking a federal appeals court ruling in Louisiana which would have prevented the abortion pill mifepristone from being prescribed over the phone and sent through
Roche/Genentech and AstraZeneca…
Roche/Genentech and AstraZeneca have the best-performing medical science liaison (MSL) teams in oncology, according to a ZoomRx survey of physicians.
Despite a prolonged period of…
Despite a prolonged period of policy uncertainty in the U.S.—and the ripple effects across the global life sciences and healthcare industries—executives at health companies are still seeing opportunities amid the tumult.
Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss.
The Strange Alliance Trying to Remake American Psychiatry
The Department of Health and critical psychiatry activists are hoping to upend 40 years of medical orthodoxy.
As biologics have increasingly…
As biologics have increasingly superseded small molecules in the biopharma industry’s pipeline, the mounting complexity of their manufacturing products is putting production and launches under pressure.
BridgeBio Pharma is teaming up…
BridgeBio Pharma is teaming up with BlackDoctor and HealthyWomen to highlight how the heart condition ATTR-cardiac amyloidosis (ATTR-CM) is being “systematically missed in women.”
Supreme Court Allows Abortion Pill Access by Mail to Continue
A federal appeals court ruling against the Food and Drug Administration would have restricted access by mail to mifepristone.
To secure an exemption from 100%…
To secure an exemption from 100% tariffs on imported drugs to the U.S., companies that have not made MFN pricing deals with the government will be required to provide detailed information on their investment and
Doceree has bold ambitions to…
Doceree has bold ambitions to bring to a new software category to pharma brand teams, one that reshapes campaign deployment in the artificial intelligence era.